ONS-3010 (adalimumab biosimilar) - Zhejiang Huahai Pharma, Viropro, Outlook Therap, Ipca Labs, Liomont, Ligand
http://ir.oncobiologics.com/phoenix.zhtml?c=254316&p=irol-newsArticle&ID=2332432
 
Mar 22, 2018
 
Next